ClinConnect ClinConnect Logo
Search / Trial NCT03320967

Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients

Launched by VINCENZO CANNIZZARO · Oct 20, 2017

Trial Information

Current as of June 15, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: first day of life until 18th birthday.
  • Ability of the care taker or the adolescent (if≥14 years of age) to understand verbal and written instructions and informed consent in German.
  • Exclusion Criteria:
  • Care taker or adolescent (if ≥14 years of age) unwilling to give written informed consent.
  • Care taker or adolescent (if ≥14 years of age) not understanding German and without a family member able to translate.
  • Adolescent (if ≥14 years of age) unwilling to give written informed consent following sedation \< 24 hours.
  • Care takers of long-term sedated (\>24 hours) adolescents (if ≥14 years of age) unwilling to give written informed consent or not present within 24 hours.

About Vincenzo Cannizzaro

Vincenzo Cannizzaro is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical development, he focuses on innovative therapeutic solutions across various disease areas. His approach emphasizes rigorous scientific methodologies, regulatory compliance, and collaboration with healthcare professionals to ensure the highest standards of trial execution. Through strategic partnerships and a patient-centered philosophy, Cannizzaro aims to contribute significantly to the evolving landscape of healthcare and enhance the quality of life for patients around the globe.

Locations

Zürich, , Switzerland

Patients applied

0 patients applied

Trial Officials

Vinzenco Cannizzaro, MD, PhD

Study Director

University Children's Hospital, Zurich

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials